Nomura Holdings Inc. decreased its stake in Clorox Co. (NYSE:CLX) by 12.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,546 shares of the company’s stock after selling 3,654 shares during the period. Nomura Holdings Inc.’s holdings in Clorox were worth $3,522,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of CLX. Sadoff Investment Management LLC bought a new stake in shares of Clorox during the first quarter valued at about $14,639,000. PGGM Investments raised its position in Clorox by 3.4% in the first quarter. PGGM Investments now owns 110,406 shares of the company’s stock worth $13,918,000 after buying an additional 3,645 shares in the last quarter. UMB Bank N A MO raised its position in Clorox by 18.2% in the first quarter. UMB Bank N A MO now owns 53,810 shares of the company’s stock worth $6,784,000 after buying an additional 8,299 shares in the last quarter. Raymond James Trust N.A. raised its position in Clorox by 41.3% in the first quarter. Raymond James Trust N.A. now owns 7,526 shares of the company’s stock worth $949,000 after buying an additional 2,200 shares in the last quarter. Finally, Carroll Financial Associates Inc. raised its position in Clorox by 4.1% in the first quarter. Carroll Financial Associates Inc. now owns 3,348 shares of the company’s stock worth $422,000 after buying an additional 131 shares in the last quarter. Institutional investors own 70.26% of the company’s stock.

Shares of Clorox Co. (NYSE:CLX) opened at 123.44 on Wednesday. Clorox Co. has a 12-month low of $113.37 and a 12-month high of $140.47. The stock’s 50 day moving average is $129.50 and its 200-day moving average is $130.10. The company has a market capitalization of $15.98 billion, a P/E ratio of 25.09 and a beta of 0.33.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same period in the prior year, the company posted $1.44 earnings per share. The firm’s quarterly revenue was up 2.8% on a year-over-year basis. Analysts anticipate that Clorox Co. will post $5.49 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Monday, October 24th. This represents a $3.20 dividend on an annualized basis and a yield of 2.59%. Clorox’s dividend payout ratio is currently 64.91%.

A number of research firms recently weighed in on CLX. Atlantic Securities upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $144.00 price objective for the company in a research note on Friday, September 16th. B. Riley reiterated a “neutral” rating and issued a $109.00 price objective on shares of Clorox in a research note on Tuesday, August 9th. Citigroup Inc. lifted their price objective on shares of Clorox from $134.00 to $144.00 and gave the company a “neutral” rating in a research note on Monday, August 8th. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $148.00 price objective for the company in a research note on Monday, August 8th. Finally, Goldman Sachs Group Inc. reiterated a “neutral” rating and issued a $130.00 price objective on shares of Clorox in a research note on Thursday, August 4th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $128.90.

In other Clorox news, COO Nikolaos A. Vlahos sold 925 shares of the company’s stock in a transaction that occurred on Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total transaction of $123,089.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Laura Stein sold 38,882 shares of the stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares of the company’s stock, valued at $6,387,096.69. The disclosure for this sale can be found here. Company insiders own 2.09% of the company’s stock.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).

Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.